Gelatin gel as a carrier of platelet-derived growth factors

Journal of Biomaterials Applications

Volumn 28, Issue 4, 2013, Pages 595-606

  Suzuki, Shuko ^a,b   Morimoto, Natsumi ^a   Ikada, Yoshito ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

carrier; Gelatin gel; growth factor; platelet rich fibrin; platelet rich plasma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CARRIER; GROWTH FACTOR; NEO-VASCULARIZATION; PHOSPHATE-BUFFERED SALINES; PLATELET RICH PLASMA; PLATELET-DERIVED GROWTH FACTORS; PLATELET-RICH FIBRIN;

PLASMA (HUMAN); REPAIR; TISSUE REGENERATION;

PLATELETS;

FIBRIN; FIBROBLAST GROWTH FACTOR 2; GELATIN; GROWTH FACTOR; HYDROXYPROLINE; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1;

ANALYZER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEGRADATION; DOG; ELISA KIT; EXTRACTION; GEL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SKIN DEFECT; SPECTROPHOTOMETER; THROMBOCYTE; THROMBOCYTE RICH PLASMA; WOUND DRESSING;

CARRIER; GELATIN GEL; GROWTH FACTOR; PLATELET-RICH FIBRIN; PLATELET-RICH PLASMA;

ANIMALS; DOGS; FEMALE; GELATIN; GELS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; SWINE;

EID: 84886779977     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328212468183     Document Type: Article

References (48)

1. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 ; 85 (6). 638-646
2. Rodriguez A, Anastassov GE, Lee H, et al. Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. J Oral Maxillofac Surg. 2003 ; 61 (2). 157-163
3. Cervelli V, Gentile P, Scioli MG, et al. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Meth. 2009 ; 15 (4). 625-634
4. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008 ; 1 (3-4). 165-174
5. Saad Setta H, Elshahat A, Elsherbiny K, et al. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wound J. 2011 ; 8 (3). 307-312
6. Cho JM, Lee YH, Baek RM, et al. Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice. J Plast Reconstr Aesthet Surg. 2011 ; 64 (2). e31 - e39
7. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001 ; 107 (1). 229-237
8. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009 ; 27 (3). 158-167
9. Nielsen HJ, Werther K, Mynster T, et al. Bacteria-induced release of white cell-and platelet-derived vascular endothelial growth factor in vitro. Vox Sang. 2001 ; 80 (3). 170-178
10. Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest. 2002 ; 62 (5). 343-350
11. Moojen DJ, Everts PA, Schure RM, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008 ; 26 (3). 404-410
12. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 ; 101 (3). e51 - e55
13. Anitua E, Sánchez M, Orive G, et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007 ; 28 (31). 4551-4560
14. Everts PA, van Zundert A, Schönberger JP, et al. What do we use: platelet-rich plasma or platelet-leukocyte gel?. J Biomed Mater Res A. 2008 ; 85 (4). 1135-1136
15. Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011 ; 39 (2). 266-271
16. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002 ; 17 (2). 184-190
17. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 ; 101 (3). e37 - e44
18. Lucarelli E, Beretta R, Dozza B, et al. A recently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater. 2010 ; 20: 13-23
19. Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. J Control Release. 2010 ; 148 (1). 49-55
20. Borzini P, Mazzucco L. Platelet gels and releasates. Curr Opin Hematol. 2005 ; 12 (6). 473-479
21. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 ; 62 (4). 489-496
22. Senet P, Bon FX, Benbunan M, et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg. 2003 ; 38 (6). 1342-1348
23. Carreon LY, Glassman SD, Anekstein Y, et al. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine. 2005 ; 30 (9). E243 - E246
24. Roldán JC, Jepsen S, Miller J, et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone. 2004 ; 34 (1). 80-90
25. Castro FP. Role of activated growth factors in lumbar spinal fusions. J Spinal Disord Tech. 2004 ; 17 (5). 380-384
26. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, et al. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009 ; 27 (1). 63-69
27. Su CY, Kuo YP, Tseng YH, et al. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 ; 108 (1). 56-61
28. Roy S, Driggs J, Elgharably H, et al. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen. 2011 ; 19 (6). 753-766
29. Gassling VL, Açil Y, Springer IN, et al. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 ; 108 (1). 48-55
30. Hokugo A, Sawada Y, Hokugo R, et al. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 ; 104 (1). 44-48
31. Bir SC, Esaki J, Marui A, et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. J Vasc Surg. 2009 ; 50 (4). 870-879
32. Matsui M, Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater. 2012 ; 8 (5). 1792-1801
33. Lu HH, Vo JM, Chin HS, et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A. 2008 ; 86 (4). 1128-1136
34. Takikawa M, Nakamura S, Nakamura S, et al. Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles. J Biomed Mater Res B Appl Biomater. 2011 ; 97 (2). 373-380
35. Suzuki S and Ikada Y. Sealing effects of cross-linked gelatin. J Biomater Appl. Epub ahead of print 24 January 2012. DOI: 10.1177/0885328211426491.
36. Kakudo N, Minakata T, Mitsui T, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008 ; 122 (5). 1352-1360
37. Dohan Ehrenfest DM, Del Corso M, Diss A, et al. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol. 2010 ; 81 (4). 546-555
38. Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release. 1994 ; 31 (2). 189-199
39. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem. 1996 ; 29 (3). 225-229
40. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2001 ; 10 (4). 225-228
41. Tabata Y, Nagano A, Munirzzaman M, et al. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials. 1998 ; 19 (19). 1781-1789
42. Takahashi Y, Yamamoto M, Yamada K, et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 form a biodegradable hydrogel. Tissue Eng. 2007 ; 13 (2). 293-300
43. Hong L, Tabata Y, Miyamoto S, et al. Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg. 2000 ; 92 (2). 315-325
44. Asamura S, Mochizuki Y, Yamamoto M, et al. Bone regeneration using a bone morphogenetic protein-2 saturated slow-release gelatin hydrogel sheet: evaluation in a canine orbital floor fracture model. Ann Plast Surg. 2010 ; 64 (4). 496-502
45. Okamoto T, Yamamoto Y, Gotoh M, et al. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J Thorac Cardiovasc Surg. 2004 ; 127 (2). 329-334
46. Harrison S, Vavken P, Kevy S, et al. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med. 2011 ; 39 (4). 729-734
47. Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in plattelet-rich plasma on peri-implant bone regeneration. Bone. 2004 ; 34 (4). 665-671
48. Ovington LG. Advances in wound dressings. Clin Dermatol. 2007 ; 25 (1). 33-38